Bristol-Myers Squibb Company
CYCLIC DINUCLEOTIDES AS ANTICANCER AGENTS
Last updated:
Abstract:
The present invention is directed to compounds of the formula (I) wherein all substituents are defined herein, as well as pharmaceutically acceptable compositions comprising compounds of the invention and methods of using said compositions in the treatment of various disorders. ##STR00001##
Status:
Application
Type:
Utility
Filling date:
30 Aug 2018
Issue date:
16 Jul 2020